TechFlow, October 7 — According to Globenewswire, MAIA Biotechnology, listed on NYSE American, a subsidiary of the New York Stock Exchange, announced the official launch of its digital asset treasury. Its board has approved allocating 90% of the company's liquid assets to invest in top-tier cryptocurrencies. The initial investment will purchase BTC, ETH, and USDC. The company also plans to establish a digital asset advisory committee to support related acquisition transactions.
Navigating Web3 tides with focused insights
Contribute An Article
Media Requests
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号




